NCT07518381Not yet recruiting
Medication Understanding in MS
Home-based Assessment of Medication Understanding and Use in People With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 8 Apr 2026
Brief summary (registry, in English)
The goal of this observational study is to learn how people with multiple sclerosis (MS) understand, organise, and use their medicines at home. The study aims to explore how people take their prescribed and non-prescribed medicines, what challenges they experience, and whether any safety issues arise in day-to-day medication use. Participants will take part in one home visit with trained student researchers. During the visit, researchers will review all medicines and supplements the participant uses, ask about routines and any difficulties, check medication packaging with permission, and ask a brief question about memory. No treatment changes will be made. Information will be reviewed by a senior clinician, and any safety concerns will be shared with the participant's usual healthcare team.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 25 Mar 2026
- Start date
- 15 Apr 2026
- Primary completion date
- 15 Jul 2026
- Lead sponsor
- University of Nottingham
- Diseases
- Multiple sclerosis
- NCT number
- NCT07518381
What you commit to
- Study type: Observational
- Planned participants: 80
- From 15 Apr 2026 to the primary completion date, 15 Jul 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive or communication impairment without a consultee to provide consultee declaration and medication-related information
Other
- Participants for whom a home visit is deemed unsafe
- Non-English speakers
Who the study is looking for
- Adults aged 18 years and over with a confirmed diagnosis of multiple sclerosis
- Living in the community (not in residential care)
- Taking at least one prescribed medication
- Able to provide informed consent or, for those without capacity to provide informed consent, with a consultee available to provide consultee declaration and provide information during home-based medication review
- Willing and able to participate in a home-based medication review
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.